Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results
Product sales and royalty revenue of $7.0 million up 118% from Q3 2022, representing the eleventh straight quarter of sequential product sales and royalty revenue growthGenerated $0.9 million in posit...